Dermoglass in the media
CaixaImpulse
Dermoglass technology takes the leap into the pharmaceutical industry
Dermoglass becomes the first project funded by the CaixaImpulse program to be licensed to a pharmaceutical company, Laboratorios ERN. It is a new technology to tackle chronic ulcers developed by the research group “Biomaterials for Regenerative Therapies” led by Dr. Elisabeth Engel at the Institute for Bioengineering of Catalonia (IBEC), who is also Professor at Polytechnic University of Catalonia (UPC).
IBEC technology against malaria gets new impulse
The project led by IBEC researcher Elena Lantero from Nanomalaria IBEC-ISGlobal Joint Group, gets funding from CaixaImpulse Validate program to develop a new technology for rapid, cheap and efficient diagnosis of a disease which threats millions of people worldwide.
The project led by IBEC researcher Elena Lantero from Nanomalaria IBEC-ISGlobal Joint Group, gets funding from CaixaImpulse Validate program to develop a new technology for rapid, cheap and efficient diagnosis of a disease which threats millions of people worldwide.Despite being preventable and treatable, malaria is an infectious disease that threatens the life of 3.2 billion people globally. Only in 2018, an estimated 228 million cases of malaria occurred worldwide, accounting for hundreds of thousands of deaths.